Cargando…
The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis
OBJECTIVE: To systematically evaluate the effectiveness of exposure and response prevention (ERP) combined with medication on obsessive-compulsive disorder (OCD). METHODS: PubMed, Web of Science, EBSCO, Cochrane, Embase, and Science Direct databases were searched to include randomized controlled tri...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520065/ https://www.ncbi.nlm.nih.gov/pubmed/36186855 http://dx.doi.org/10.3389/fpsyt.2022.973838 |
_version_ | 1784799540411367424 |
---|---|
author | Mao, Lingyun Hu, Maorong Luo, Lan Wu, Yunhong Lu, Zihang Zou, Jingzhi |
author_facet | Mao, Lingyun Hu, Maorong Luo, Lan Wu, Yunhong Lu, Zihang Zou, Jingzhi |
author_sort | Mao, Lingyun |
collection | PubMed |
description | OBJECTIVE: To systematically evaluate the effectiveness of exposure and response prevention (ERP) combined with medication on obsessive-compulsive disorder (OCD). METHODS: PubMed, Web of Science, EBSCO, Cochrane, Embase, and Science Direct databases were searched to include randomized controlled trials of ERP combined with medication for OCD that met the criteria. The Yale Brown Obsessive Compulsive Scale was used as the primary outcome indicator, and Depression scales were used as secondary outcome indicators. An evaluation of bias risk was conducted to identify possible sources of bias based on methodological and clinical factors. Review Manager 5.3 and Stata 16.0 software was used to perform meta-analysis of the extracted data. RESULTS: A total of 21 studies with 1113 patients were included. Meta-analysis showed that ERP combined with medication therapy was significantly better than medication therapy alone including selective serotonin reuptake inhibitors, clomipramine and risperidone (MD = –6.60, 95% CI: –8.35 to –4.84, P < 0.00001), but D-cycloserine (DCS) drugs do not enhance the effect of ERP intervention in patients with OCD (MD = 0.15, 95% CI: –0.87 to 1.17, P = 0.77). There is more significant maintenance by combined treatment method of medication plus ERP than medication treatment alone during the follow-up period (MD = –7.14, 95% CI: –9.17 to –5.10, P < 0.00001). DCS drugs did not enhance the effect of ERP intervention on depression in patients with OCD (SMD = –0.08, 95% CI: –0.31 to 0.15, P = 0.50). ERP combined with drug improved patients’ depression levels significantly better than providing drug alone (SMD = –0.40, 95% CI: –0.68 to –0.11, P = 0.006). CONCLUSION: Patients with OCD have significant improvement in symptoms of obsessive-compulsive disorder and depression when ERP is combined with medication, however, not enough to prove that DCS can enhance ERP effectiveness. |
format | Online Article Text |
id | pubmed-9520065 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95200652022-09-30 The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis Mao, Lingyun Hu, Maorong Luo, Lan Wu, Yunhong Lu, Zihang Zou, Jingzhi Front Psychiatry Psychiatry OBJECTIVE: To systematically evaluate the effectiveness of exposure and response prevention (ERP) combined with medication on obsessive-compulsive disorder (OCD). METHODS: PubMed, Web of Science, EBSCO, Cochrane, Embase, and Science Direct databases were searched to include randomized controlled trials of ERP combined with medication for OCD that met the criteria. The Yale Brown Obsessive Compulsive Scale was used as the primary outcome indicator, and Depression scales were used as secondary outcome indicators. An evaluation of bias risk was conducted to identify possible sources of bias based on methodological and clinical factors. Review Manager 5.3 and Stata 16.0 software was used to perform meta-analysis of the extracted data. RESULTS: A total of 21 studies with 1113 patients were included. Meta-analysis showed that ERP combined with medication therapy was significantly better than medication therapy alone including selective serotonin reuptake inhibitors, clomipramine and risperidone (MD = –6.60, 95% CI: –8.35 to –4.84, P < 0.00001), but D-cycloserine (DCS) drugs do not enhance the effect of ERP intervention in patients with OCD (MD = 0.15, 95% CI: –0.87 to 1.17, P = 0.77). There is more significant maintenance by combined treatment method of medication plus ERP than medication treatment alone during the follow-up period (MD = –7.14, 95% CI: –9.17 to –5.10, P < 0.00001). DCS drugs did not enhance the effect of ERP intervention on depression in patients with OCD (SMD = –0.08, 95% CI: –0.31 to 0.15, P = 0.50). ERP combined with drug improved patients’ depression levels significantly better than providing drug alone (SMD = –0.40, 95% CI: –0.68 to –0.11, P = 0.006). CONCLUSION: Patients with OCD have significant improvement in symptoms of obsessive-compulsive disorder and depression when ERP is combined with medication, however, not enough to prove that DCS can enhance ERP effectiveness. Frontiers Media S.A. 2022-09-15 /pmc/articles/PMC9520065/ /pubmed/36186855 http://dx.doi.org/10.3389/fpsyt.2022.973838 Text en Copyright © 2022 Mao, Hu, Luo, Wu, Lu and Zou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Mao, Lingyun Hu, Maorong Luo, Lan Wu, Yunhong Lu, Zihang Zou, Jingzhi The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis |
title | The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis |
title_full | The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis |
title_fullStr | The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis |
title_full_unstemmed | The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis |
title_short | The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis |
title_sort | effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: a systematic review and meta-analysis |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520065/ https://www.ncbi.nlm.nih.gov/pubmed/36186855 http://dx.doi.org/10.3389/fpsyt.2022.973838 |
work_keys_str_mv | AT maolingyun theeffectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis AT humaorong theeffectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis AT luolan theeffectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis AT wuyunhong theeffectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis AT luzihang theeffectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis AT zoujingzhi theeffectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis AT maolingyun effectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis AT humaorong effectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis AT luolan effectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis AT wuyunhong effectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis AT luzihang effectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis AT zoujingzhi effectivenessofexposureandresponsepreventioncombinedwithpharmacotherapyforobsessivecompulsivedisorderasystematicreviewandmetaanalysis |